About
Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world's first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.
Technologies
OutlookMicrosoft Office 365Google Cloud HostingWordPress.orgNginxEventbriteBootstrap FrameworkGoogle Font APIMobile FriendlyRemoteDomoSisenseKNIME
Keywords
agetechbioelectonicsneurosciencesportstechspace medicinemedical equipment manufacturingclinical researchmedical equipment and supplies manufacturingdigital healthgovernmentdigital healthcare innovationmicrogravity health solutionsneuroplasticity waveformsservicesmachine learning biomarkerswearable neurostimulation devicespace-microgravity health solutionsspace medicine applicationsremote patient monitoringvestibular system stimulationneurostimulationdeep space healthcaremedical technologypersonalized neuromotor therapyneuroplasticity therapyelderly care technologyremote diagnosticswearable balance diagnosticsbioelectronic biomarkersbioelectronic device
Company Information
- Employees6
- Founded2022
Location
659 Oak Grove Ave, Menlo Park, California, United States, 94025-4317
